SING GEORGE L 4
4 · REGENERON PHARMACEUTICALS, INC. · Filed May 6, 2024
Insider Transaction Report
Form 4
SING GEORGE L
Director
Transactions
- Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2024-05-03−2,000→ 3,338 totalExercise: $413.33Exp: 2025-01-02→ Common Stock (2,000 underlying) - Tax Payment
Common Stock
2024-05-03$942.53/sh−877$826,599→ 27,472 total - Exercise/Conversion
Common Stock
2024-05-03$413.33/sh+2,000$826,660→ 28,349 total
Holdings
- 750(indirect: By Spouse)
Common Stock
- 400(indirect: By Spouse)
Common Stock
- 1,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.